Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial (P-SCIP)

9. mars 2016 oppdatert av: Rutgers, The State University of New Jersey
The investigators have developed a parent social-cognitive processing intervention (P-SCIP) to help decrease distress among parent caregivers of children undergoing hematopoietic stem cell transplant (HSCT). The investigators will evaluate the efficacy of P-SCIP in reducing short- and long-term distress and parenting stress among 300 parents of children undergoing HSCT. P-SCIP will be delivered during the child's inpatient HSCT hospitalization and is specifically designed to improve parent social (e.g., sharing concerns) and cognitive (e.g., acceptance) processing of the transplant experience. The intervention includes five in-person sessions that are accompanied by an interactive CD-ROM. The CD-ROM complements the materials in the in-person sessions and provides parents with the opportunity to enhance and deepen their cognitive and social processing of the HSCT experience. The intervention will be tested against best-practices psychosocial care (BPC) available in four enriched pediatric HSCT settings across the United States. P-SCIP will be provided to both Spanish- and English-speaking parents. Participants will complete measures of psychological distress, well-being, and social and cognitive processing at the time of HSCT, two, six and twelve months after HSCT. Research questions will address the effects of P-SCIP versus BPC on parent psychological adaptation and social and cognitive processing, as well as evaluate parent personal resources as well as child medical course variables that contribute to intervention response. The investigators will also examine barriers to participation in the intervention by comparing barriers to participation among parents who refuse participation in the trial and parents who accept.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

212

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Forente stater
    • California
      • Los Angeles, California, Forente stater, 90027
        • Childrens Hospital Los Angeles
    • Georgia
      • Atlanta, Georgia, Forente stater, 30322
        • Emory University/Childrens Healthcare of Atlanta
    • New Jersey
      • New Brunswick, New Jersey, Forente stater, 080903
        • Rutgers Cancer Institute of New Jersey
    • New York
      • New York, New York, Forente stater, 10021
        • Memorial Sloan-Kettering Cancer Center
      • New York, New York, Forente stater, 10032
        • Columbia University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • biological or foster parent of children under 19 years of age who are scheduled for HSCT within the next month
  • participant is the primary caregiver
  • participant must have phone service
  • caregiver speaks, reads, and writes English or Spanish (Spanish is for Childrens Hospital Los Angeles and Columbia University only)

Exclusion Criteria:

  • pediatric patient has a diagnosis of medulloblastoma or other cancer of the brain

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: P-SCIP
Arm I (Parent Social-Cognitive Intervention Program [P-SCIP]): Participants undergo five 60-minute behavioral intervention sessions once or twice weekly for 3 weeks to learn how to engage in effective social and cognitive processing to deal with fears and worries about the transplant and transplant-related concerns. Participants receive a laptop computer and a CD-ROM after the first session.
Atferdsmessig: Behavioral intervention sessions
Participants undergo five 60-minute behavioral intervention sessions once or twice weekly for 3 weeks to learn how to engage in effective social and cognitive processing to deal with fears and worries about the transplant and transplant-related concerns.
Annen: CD-ROM
Participants receive a laptop computer and a CD-ROM after the first session of behavioral intervention.
Eksperimentell: BPC
Arm II (Best-recommended Psychosocial Care [BPC]): Participants undergo usual care and receive a "Discovery to Recovery" DVD and pamphlet developed by the National Marrow Donor Program (NMDP) describing psychological issues associated with hematopoietic stem cell transplantation (HSCT), the booklet "Top Tips for Parent Caregivers During the BMT Process" published by National Marrow Donor Program-Link describing caregiver issues during HSCT and advice on how to handle them, 2 walkie-talkies, a laptop to view the DVD, and 5 hours of respite care from a child-life specialist once or twice weekly for 3 weeks.
Annen: DVD and pamphlet
Participants receive a "Discovery to Recovery" DVD and pamphlet developed by the National Marrow Donor Program (NMDP) describing psychological issues associated with hematopoietic stem cell transplantation (HSCT), the booklet "Top Tips for Parent Caregivers During the BMT Process" published by National Marrow Donor Program-Link describing caregiver issues during HSCT and advice on how to handle them, 2 walkie-talkies, a laptop to view the DVD.
Annen: Respite care
Participants receive 5 hours of respite care from a child-life specialist once or twice weekly for 3 weeks.

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
Beck Depression Inventory
Tidsramme: 7 years
7 years
Beck Anxiety Inventory
Tidsramme: 7 years
7 years
Mental Health Inventory
Tidsramme: 7 years
7 years
Impact of Events Scale-Revised
Tidsramme: 7 years
7 years
Axis I Structured Clinical Interview for DSM-IV (SCID)
Tidsramme: 7 years
7 years

Sekundære resultatmål

Resultatmål
Tidsramme
Fear Structure
Tidsramme: 7 years
7 years
Brief COPE
Tidsramme: 7 years
7 years

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Rutgers, The State University of New Jersey

Samarbeidspartnere

National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Columbia University
Icahn School of Medicine at Mount Sinai
Emory University
Weill Medical College of Cornell University
Children's Hospital Los Angeles
University of Medicine and Dentistry of New Jersey
National Marrow Donor Program

Etterforskere

  • Hovedetterforsker: Sharon L Manne, Ph.D., Rutgers Cancer Institute of New Jersey

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. mai 2010

Primær fullføring (Faktiske)

1. januar 2015

Studiet fullført (Faktiske)

1. mai 2015

Datoer for studieregistrering

Først innsendt

14. juli 2009

Først innsendt som oppfylte QC-kriteriene

14. juli 2009

Først lagt ut (Anslag)

15. juli 2009

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

10. mars 2016

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. mars 2016

Sist bekreftet

1. mars 2016

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Andre studie-ID-numre

  • 130906
  • P30CA072720 (U.S. NIH-stipend/kontrakt)
  • 1R01CA127488-01A1 (U.S. NIH-stipend/kontrakt)
  • CDR0000632012 (Registeridentifikator: PDQ (Physician Data Query))
  • FCCC-07848
  • 0220090280 (Annen identifikator: IRB Number)
  • IRB#07-848; 15032-01 (Annen identifikator: Fox Chase number)

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere